Parimer Scientific is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development of small-molecule drugs. Based in South Carolina, USA, we provide comprehensive support for API development, from the initial developmental phase through clinical trials and into kilo-scale cGMP production. Our expertise lies in supporting new chemical entities (NCEs) and tackling unique chemical challenges. As a nimble and driven company founded in 2018, Parimer has rapidly grown to support over 30 emerging biotechnology companies.

Partnering with Parimer means having direct access to the owner and your project manager, ensuring you can reach out anytime. We operate as an extension of your operations, integrating seamlessly with your team and functioning as 1099 contractors.